Virtual reality (VR) training platform Osso VR is expanding to include additional modules in interventional surgical procedures and endoscopy.

The company, which was founded in 2016 by orthopaedic surgeon Justin Barad, has previously focused on orthopaedic training.

Surgeons have had limited access to real-life training opportunities as a result of the Covid-19 pandemic, making VR and augmented reality (AR) training platforms increasingly popular.

Barad said: “As an orthopaedic surgeon I have seen first-hand the need for an on-demand training and assessment tool for healthcare professionals.

“Initially Osso VR started mainly in orthopaedics, but what we have found is the unique platform we have built has been widely applicable across a range of specialties. We’re excited to formally launch this expansion in order to reach more healthcare professionals in order to provide value for their patients.

“This is an important milestone in Osso’s ambitious mission to improve patient outcomes, increase the adoption of high-value medical technology, and democratise access to surgical education worldwide.”

Osso VR is the first training platform to incorporate assessment into its modules, objectively measuring the trainee’s knowledge of steps, level of precision and overall efficiency throughout the procedure to provide a benchmark for proficiency.

The platform also aims for exceptional realism compared to other VR surgical training tools, developed by a medical illustration team from the videogame and film industries to improve the visual fidelity of the platform and provide a “cinema-quality immersive experience”.

This includes alums from Electronic Arts, Microsoft, and Apple, as well as Oscar-winning art director Jonathan Sabella.

In September, Osso announced the completion of a $14m Series A funding round led by Kaiser Permanente Ventures, with participation from SignalFire, GSR, Scrum Ventures, Leslie Ventures and OCA Ventures.

Osso is currently used in 20 countries by over 20 teaching hospitals and 14 medical device companies.